Format

Send to

Choose Destination
See comment in PubMed Commons below

Long-acting insulin analogues in the treatment of diabetes mellitus type 2: Executive summary of final report A05-03, Version 1.1.

Source

Institute for Quality and Efficiency in Health Care: Executive Summaries [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2005-.
2009 Feb 26.

Excerpt

The aims of this research were: the benefit assessment of long-term therapy with an LAIA (insulin glargine or insulin detemir) compared with treatment with a longer-acting insulin based on human insulin; the benefit assessment of LAIAs compared with each other, in each case in patients with diabetes mellitus type 2. The main focus of the assessment was on patient-relevant therapy goals. The benefit assessment was based on the comparison of the desired and undesired effects of the individual drugs.

© IQWiG (Institute for Quality and Efficiency in Health Care).

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Health
    Loading ...
    Write to the Help Desk